SEPN — Septerna, Inc. Common Stock · rev $46.0M

Septerna, Inc. Common Stock (SEPN) is a biotechnology company listed on NASDAQ.

Latest reported SEPN revenue for 2025-12-31 was $46.0M. Net income was -$48.9M. Revenue was up 4174.5% from 2024-12-31 to 2025-12-31. SEPN currently screens at market cap $1.61B.

Use this SEPN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SEPN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SEPN SEC filings page. Lician reads the product cache first so this HTML stays unique to Septerna, Inc. Common Stock even when a live quote feed is slow.